Kruppel-like factor 9 upregulates E-cadherin transcription and represses breast cancer invasion and metastasis

被引:1
作者
Bai, Xiaoyan [1 ]
Jiang, Xiao [2 ]
Liu, Yuting [1 ]
Wang, Yiting [1 ]
Jiang, Xuewei [1 ]
Song, Guang [1 ]
Qiu, Hongmei [1 ]
Zhang, Qinggao [1 ]
机构
[1] Dalian Univ, Med Coll, 10 Xuefu Ave, Dalian 116622, Peoples R China
[2] Dalian Municipal Cent Hosp, Dept Gastroenterol & Hepatol, Dalian, Peoples R China
来源
AMERICAN JOURNAL OF CANCER RESEARCH | 2021年 / 11卷 / 07期
基金
中国国家自然科学基金;
关键词
Kruppel like factor 9; E-cadherin; metastasis; breast cancer; CELL LUNG-CANCER; MATRIX-METALLOPROTEINASE-9; SUPPRESSES; GROWTH; EMT;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aberrant expression of Kruppel-like factor 9 (KLF9) is frequently found in some types of cancer and is implicated in cancer initiation and progression. However, the effects of KLF9 on cancer metastases and the underlying mechanisms still need to be understood. Here, we found that KLF9 evidently inhibited the capabilities of migration and invasion of breast cancer cells. The expression of KLF9 was markedly decreased in breast cancer patients compared with benign tumors, and was positively correlated with the expression of E-cadherin in the tissues of breast cancer patients. Mechanistically, chromatin immunoprecipitation combined with site-directed mutagenesisluciferase assay revealed that KLF9 activated the E-cadherin promoter by binding to GT-box elements located +84 bp and -143 bp from the TSS in the E-cadherin promoter, leading to elevated expression of E-cadherin mRNA and protein. In vivo experiments confirmed that KLF9 strongly inhibited the lung metastasis of breast cancer and increased mouse E-cadherin expression in 4T1 mouse breast cancer cells. Taken together, our findings demonstrated that KLF9 could suppress breast cancer invasion and metastasis by upregulating E cadherin, which provided new insight into aggressive treatment of breast cancer by targeting the KLF9/E-cadherin axis.
引用
收藏
页码:3660 / 3673
页数:14
相关论文
共 35 条
  • [1] Kruppel-like factor 9 down-regulates matrix metalloproteinase 9 transcription and suppresses human breast cancer invasion
    Bai, Xiao-Yan
    Li, Shujing
    Wang, Miao
    Li, Xiahui
    Yang, Yangyang
    Xu, Zhaowei
    Li, Bowen
    Li, Yanan
    Xia, Kangkai
    Chen, Huan
    Wu, Huijian
    [J]. CANCER LETTERS, 2018, 412 : 224 - 235
  • [2] THBS4 predicts poor outcomes and promotes proliferation and metastasis in gastric cancer
    Chen, Xiangbo
    Huang, Yisen
    Wang, Yubin
    Wu, Qiuli
    Hong, Shunzhong
    Huang, Zicheng
    [J]. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2019, 75 (01) : 117 - 123
  • [3] Collective Invasion in Breast Cancer Requires a Conserved Basal Epithelial Program
    Cheung, Kevin J.
    Gabrielson, Edward
    Werb, Zena
    Ewald, Andrew J.
    [J]. CELL, 2013, 155 (07) : 1639 - 1651
  • [4] Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent E-cadherin loss in ovarian carcinoma cells
    Dahl, Karen D. Cowden
    Symowicz, Jaime
    Ning, Yan
    Gutierrez, Elisa
    Fishman, David A.
    Adley, Brian P.
    Stack, M. Sharon
    Hudson, Laurie G.
    [J]. CANCER RESEARCH, 2008, 68 (12) : 4606 - 4613
  • [5] MiRNA-20a-5p accelerates the proliferation and invasion of non-small cell lung cancer by targeting and downregulating KLF9
    Fang, Q-Y
    Deng, Q-F
    Luo, J.
    Zhou, C-C
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (05) : 2548 - 2556
  • [6] Cyclin B1 Suppresses Colorectal Cancer Invasion and Metastasis by Regulating E-Cadherin
    Fang, Yifeng
    Liang, Xiao
    Jiang, Wenbin
    Li, Jianbo
    Xu, Junfen
    Cai, Xiujun
    [J]. PLOS ONE, 2015, 10 (05):
  • [7] RARγ-induced E-cadherin downregulation promotes hepatocellular carcinoma invasion and metastasis
    Gan, Wen-Juan
    Wang, Jing-Ru
    Zhu, Xiao-Li
    He, Xiao-Shun
    Guo, Peng-Da
    Zhang, Shen
    Li, Xiu-Ming
    Li, Jian-Ming
    Wu, Hua
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2016, 35
  • [8] Role of E boxes in the repression of E-cadherin expression
    Giroldi, LA
    Bringuier, PP
    de Weijert, M
    Jansen, C
    van Bokhoven, A
    Schalken, JA
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 241 (02) : 453 - 458
  • [9] Current issues in ER and HER2 testing by IHC in breast cancer
    Gown, Allen M.
    [J]. MODERN PATHOLOGY, 2008, 21 : S8 - S15
  • [10] Hu W, 2020, AM J CANCER RES, V10, P630